These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24722062)

  • 1. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
    Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
    Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
    Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
    Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.
    Fontugne J; Davis K; Palanisamy N; Udager A; Mehra R; McDaniel AS; Siddiqui J; Rubin MA; Mosquera JM; Tomlins SA
    Mod Pathol; 2016 Feb; 29(2):157-65. PubMed ID: 26743468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
    Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
    Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.
    Brooks JD; Wei W; Hawley S; Auman H; Newcomb L; Boyer H; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Carroll PR; Gleave M; Lance R; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; McKenney JK
    PLoS One; 2015; 10(7):e0132343. PubMed ID: 26172920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
    Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
    Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.
    Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O
    Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
    Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
    BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
    Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
    Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.
    Bhalla R; Kunju LP; Tomlins SA; Christopherson K; Cortez C; Carskadon S; Siddiqui J; Park K; Mosquera JM; Pestano GA; Rubin MA; Chinnaiyan AM; Palanisamy N
    Mod Pathol; 2013 Jun; 26(6):835-48. PubMed ID: 23348902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Interaction of
    Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
    Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.
    Grupp K; Diebel F; Sirma H; Simon R; Breitmeyer K; Steurer S; Hube-Magg C; Prien K; Pham T; Weigand P; Michl U; Heinzer H; Kluth M; Minner S; Tsourlakis MC; Izbicki JR; Sauter G; Schlomm T; Wilczak W
    Prostate; 2013 Nov; 73(15):1690-8. PubMed ID: 23843146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
    Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
    Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
    BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
    Terry S; Nicolaiew N; Basset V; Semprez F; Soyeux P; Maillé P; Vacherot F; Ploussard G; Londoño-Vallejo A; de la Taille A; Allory Y
    Cancer; 2015 May; 121(9):1422-30. PubMed ID: 25639219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
    Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
    J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
    Fontugne J; Cai PY; Alnajar H; Bhinder B; Park K; Ye H; Beg S; Sailer V; Siddiqui J; Blattner-Johnson M; Croyle JA; Noorzad Z; Calagua C; MacDonald TY; Axcrona U; Bogaard M; Axcrona K; Scherr DS; Sanda MG; Johannessen B; Chinnaiyan AM; Elemento O; Skotheim RI; Rubin MA; Barbieri CE; Mosquera JM
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35050902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPINK1 protein expression and prostate cancer progression.
    Flavin R; Pettersson A; Hendrickson WK; Fiorentino M; Finn S; Kunz L; Judson GL; Lis R; Bailey D; Fiore C; Nuttall E; Martin NE; Stack E; Penney KL; Rider JR; Sinnott J; Sweeney C; Sesso HD; Fall K; Giovannucci E; Kantoff P; Stampfer M; Loda M; Mucci LA
    Clin Cancer Res; 2014 Sep; 20(18):4904-11. PubMed ID: 24687926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.
    Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS
    PLoS Genet; 2015 Jan; 11(1):e1004930. PubMed ID: 25629170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.